NCT02122471

Brief Summary

The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,410

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2014

Shorter than P25 for phase_3

Geographic Reach
1 country

167 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 24, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
3.7 years until next milestone

Results Posted

Study results publicly available

March 14, 2019

Completed
Last Updated

May 28, 2019

Status Verified

May 1, 2019

Enrollment Period

1.1 years

First QC Date

April 22, 2014

Results QC Date

November 28, 2018

Last Update Submit

May 23, 2019

Conditions

Keywords

CICConstipationChronic ConstipationSynergyPlecanatide

Outcome Measures

Primary Outcomes (1)

  • Number of Durable Overall CSBM Responders, Mean Replacement Approach

    The primary efficacy endpoint was measured by the number of durable overall CSBM responders over the 12-week Treatment Period. A durable overall CSBM responder was defined as a weekly CSBM responder for at least 9 of the 12 treatment weeks, including at least 3 of the last 4 weeks. A CSBM weekly responder was defined as a patient who has ≥ 3 Complete Spontaneous Bowel Movements (CSBMs) per week and an increase from baseline of ≥1 CSBM for that week. A CSBM was a bowel movement that occurred in the absence of laxative use within 24 hours and was associated with the feeling of complete evacuation.

    12-Week Treatment Period

Secondary Outcomes (4)

  • Change From Baseline in CSBMs (CSBMs/Week) Over the 12-week Treatment Period , Mean Replacement Approach

    Baseline and 12 weeks

  • Change From Baseline in SBMs (SBMs/Week) Over the 12-week Treatment Period, Mean Replacement Approach

    Baseline and 12 weeks

  • Change From Baseline in Average Weekly SBM Stool Consistency Over the 12-week Treatment Period, Mean Replacement Approach

    Baseline and 12 weeks

  • Change From Baseline in Average Weekly Straining Score Over the 12-week Treatment Period, Mean Replacement Approach

    Baseline and 12 weeks

Study Arms (3)

Plecanatide 3.0 mg

EXPERIMENTAL

Plecanatide tablets 3.0 mg QD for 12 weeks

Drug: Plecanatide

Placebo

PLACEBO COMPARATOR

Matching placebo tablets QD for 12 weeks

Drug: Placebo

Plecanatide 6.0 mg

EXPERIMENTAL

Plecanatide tablets 6.0 mg QD for 12 weeks

Drug: Plecanatide

Interventions

Plecanatide 3.0 mgPlecanatide 6.0 mg
Placebo

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female aged 18-80, inclusive
  • Meets modified Rome III criteria for functional chronic idiopathic constipation for at least 3 months with symptom onset for at least 6 months
  • Completed a colonoscopy in accordance with American Gastroenterological Association (AGA) colon cancer screening guidelines (5 years), with no clinically significant findings
  • Willing to maintain a stable diet during the study

You may not qualify if:

  • Loose stool (mushy) or watery (Bristol score 6 or 7) stool in the absence of any laxative or prohibited medicine for \> 25% of Bowel Movements (BMs) during the 3 months prior to screening visit OR during the 14 day pre-treatment assessment
  • Active peptic ulcer disease, diabetes or hypertension not adequately treated or not stable
  • History of cathartic colon, laxative, enema abuse, or ischemic colitis
  • Fecal impaction within 3 months of screening
  • Patient has had /has any: diseases or conditions associated with constipation (GI or CNS), structural abnormality of the GI tract or gastric bypass surgery, pelvic floor dysfunction, pseudo-obstruction, active infectious gastritis, diverticulitis, anal fissures or any disease or condition that can affect GI motility or defecation or can be associated with abdominal pain
  • Unexplained and clinically significant "alarm symptoms" including lower GI bleeding, iron-deficiency anemia, weight loss or systemic signs of infection or colitis
  • Major surgery, stroke or myocardial infarction (MI) within 60 days of screening
  • Participated in a previous plecanatide clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (167)

Synergy Research Site

Anniston, Alabama, 36207, United States

Location

Synergy Research Site

Huntsville, Alabama, 35801, United States

Location

Synergy Research Site

Chandler, Arizona, 85224, United States

Location

Synergy Research Site

Goodyear, Arizona, 85395, United States

Location

Synergy Research Site

Tucson, Arizona, 85704, United States

Location

Synergy Research Site

Tucson, Arizona, 85710, United States

Location

Synergy Research Site

Tucson, Arizona, 85712, United States

Location

Synergy Research Site

Tucson, Arizona, 85715, United States

Location

Synergy Research Site

Tucson, Arizona, 85745, United States

Location

Synergy Research Site

Anaheim, California, 92801, United States

Location

Synergy Research Site

Artesia, California, 90701, United States

Location

Synergy Research Site

Carmichael, California, 95608, United States

Location

Synergy Research Site

Corona, California, 92879, United States

Location

Synergy Research Site

Encino, California, 91436, United States

Location

Synergy Research Site

Garden Grove, California, 92843, United States

Location

Synergy Research Site

Garden Grove, California, 92844, United States

Location

Synergy Research Site

Glendale, California, 91204, United States

Location

Synergy Research Site

La Mirada, California, 90638, United States

Location

Synergy Research Site

Laguna Hills, California, 92653, United States

Location

Synergy Research Site

Los Angeles, California, 90017, United States

Location

Synergy Research Site

Los Angeles, California, 90036, United States

Location

Synergy Research Site

Newport Beach, California, 92663, United States

Location

Synergy Research Site

Oceanside, California, 92056, United States

Location

Synergy Research Site

Orange, California, 92868, United States

Location

Synergy Research Site

Sacramento, California, 95821, United States

Location

Synergy Research Site

Sacramento, California, 95831, United States

Location

Synergy Research Site

San Bernardino, California, 92408, United States

Location

Synergy Research Site

San Diego, California, 92103, United States

Location

Synergy Research Site

Upland, California, 91786, United States

Location

Synergy Research Site

Ventura, California, 93003, United States

Location

Synergy Research Site

Denver, Colorado, 80209, United States

Location

Synergy Research Site

Littleton, Colorado, 80128, United States

Location

Synergy Research Site

Stamford, Connecticut, 06905, United States

Location

Synergy Research Site

Aventura, Florida, 33180, United States

Location

Synergy Research Site

Boynton Beach, Florida, 33472, United States

Location

Synergy Research Site

Bradenton, Florida, 34208, United States

Location

Synergy Research Site

Brandon, Florida, 33511, United States

Location

Synergy Research Site

Brooksville, Florida, 34601, United States

Location

Synergy Research Site

Clearwater, Florida, 33756, United States

Location

Synergy Research Site

DeLand, Florida, 32720, United States

Location

Synergy Research Site

Fort Lauderdale, Florida, 33312, United States

Location

Synergy Research Site

Gainesville, Florida, 32607, United States

Location

Synergy Research Site

Hialeah, Florida, 33012, United States

Location

Synergy Research Site

Hialeah, Florida, 33013, United States

Location

Synergy Research Site

Hialeah, Florida, 33016, United States

Location

Synergy Research Site

Hialeah, Florida, 33106, United States

Location

Synergy Research Site

Hollywood, Florida, 33024, United States

Location

Synergy Research Site

Homestead, Florida, 33030, United States

Location

Synergy Research Site

Jacksonville, Florida, 32256, United States

Location

Synergy Research Site

Jacksonville, Florida, 32277, United States

Location

Synergy Research Site

Miami, Florida, 33014, United States

Location

Synergy Research Site

Miami, Florida, 33015, United States

Location

Synergy Research Site

Miami, Florida, 33032, United States

Location

Synergy Research Site

Miami, Florida, 33122, United States

Location

Synergy Research Site

Miami, Florida, 33125, United States

Location

Synergy Research Site

Miami, Florida, 33126, United States

Location

Synergy Research Site

Miami, Florida, 33142, United States

Location

Synergy Research Site

Miami, Florida, 33144, United States

Location

Synergy Research Site

Miami, Florida, 33155, United States

Location

Synergy Research Site

Miami, Florida, 33157, United States

Location

Synergy Research Site

Miami, Florida, 33165, United States

Location

Synergy Research Site

Miami, Florida, 33173, United States

Location

Synergy Research Site

Miami, Florida, 33175, United States

Location

Synergy Research Site

Miami, Florida, 33176, United States

Location

Synergy Research Site

Miami, Florida, 33185, United States

Location

Synergy Research Site

Miami Lakes, Florida, 33016, United States

Location

Synergy Research Site

Miami Springs, Florida, 33166, United States

Location

Synergy Research Site

New Port Richey, Florida, 34653, United States

Location

Synergy Research Site

North Miami Beach, Florida, 33162, United States

Location

Synergy Research Site

Orlando, Florida, 32806, United States

Location

Synergy Research Site

Orlando, Florida, 32807, United States

Location

Synergy Research Site

Ormond Beach, Florida, 32174, United States

Location

Synergy Research Site

Pembroke Pines, Florida, 33026, United States

Location

Synergy Research Site

Pembroke Pines, Florida, 33028, United States

Location

Synergy Research Site

Plant City, Florida, 33563, United States

Location

Synergy Research Site

Plantation, Florida, 33324, United States

Location

Synergy Research Site

Saint Cloud, Florida, 34769, United States

Location

Synergy Research Site

Sarasota, Florida, 34242, United States

Location

Synergy Research Site

Seminole, Florida, 33777, United States

Location

Synergy Research Site

St. Petersburg, Florida, 33709, United States

Location

Synergy Research Site

Tamarac, Florida, 33319, United States

Location

Synergy Research Site

Tampa, Florida, 33607, United States

Location

Synergy Research Site

Tampa, Florida, 33614, United States

Location

Synergy Research Site

West Palm Beach, Florida, 33409, United States

Location

Synergy Research Site

Atlanta, Georgia, 30342, United States

Location

Synergy Research Site

Savannah, Georgia, 31406, United States

Location

Synergy Research Site

Snellville, Georgia, 30078, United States

Location

Synergy Research Site

Blackfoot, Idaho, 83221, United States

Location

Synergy Research Site

Boise, Idaho, 83709, United States

Location

Synergy Research Site

Chicago, Illinois, 60602, United States

Location

Synergy Research Site

Oak Lawn, Illinois, 60453, United States

Location

Synergy Research Site

Schaumburg, Illinois, 60194, United States

Location

Synergy Research Site

Evansville, Indiana, 47714, United States

Location

Synergy Research Site

Madisonville, Kentucky, 42431, United States

Location

Synergy Research Site

Owensboro, Kentucky, 42303, United States

Location

Synergy Research Site

Monroe, Louisiana, 71201, United States

Location

Synergy Research Site

Shreveport, Louisiana, 71105, United States

Location

Synergy Research Site

Columbia, Maryland, 21045, United States

Location

Synergy Research Site

Watertown, Massachusetts, 02472, United States

Location

Synergy Research Site

Buckley, Michigan, 49620, United States

Location

Synergy Research Site

St Louis, Missouri, 63141, United States

Location

Synergy Research Site

Omaha, Nebraska, 68114, United States

Location

Synergy Research Site

Las Vegas, Nevada, 89103, United States

Location

Synergy Research Site

Las Vegas, Nevada, 89106, United States

Location

Synergy Research Site

Stateline, Nevada, 89449, United States

Location

Synergy Research Site

Newington, New Hampshire, 03801, United States

Location

Synergy Research Site

Blackwood, New Jersey, 08012, United States

Location

Synergy Research Site

Albuquerque, New Mexico, 87102, United States

Location

Synergy Research Site

Albuquerque, New Mexico, 87109, United States

Location

Synergy Research Site

Elmsford, New York, 10523, United States

Location

Synergy Research Site

New Hyde Park, New York, 11040, United States

Location

Synergy Research Site

New York, New York, 10016, United States

Location

Synergy Research Site

New York, New York, 10018, United States

Location

Synergy Research Site

Cary, North Carolina, 27518, United States

Location

Synergy Research Site

Concord, North Carolina, 28025, United States

Location

Synergy Research Site

Hickory, North Carolina, 28601, United States

Location

Synergy Research Site

Hickory, North Carolina, 28602, United States

Location

Synergy Research Site

High Point, North Carolina, 27262, United States

Location

Synergy Research Site

Raleigh, North Carolina, 27609, United States

Location

Synergy Research Site

Cincinnati, Ohio, 45224, United States

Location

Synergy Research Site

Cleveland, Ohio, 44122, United States

Location

Synergy Research Site

Columbus, Ohio, 43214, United States

Location

Synergy Research Site

Kettering, Ohio, 45429, United States

Location

Synergy Research Site

Middleburg Heights, Ohio, 44130, United States

Location

Synergy Research Site

Sylvania, Ohio, 43560, United States

Location

Synergy Research Site

Wadsworth, Ohio, 44203, United States

Location

Synergy Research Site

Oklahoma City, Oklahoma, 73103, United States

Location

Synergy Research Site

Oklahoma City, Oklahoma, 73104, United States

Location

Synergy Research Site

Jenkintown, Pennsylvania, 19046, United States

Location

Synergy Research Site

Levittown, Pennsylvania, 19056, United States

Location

Synergy Research Site

Pittsburgh, Pennsylvania, 15206, United States

Location

Synergy Research Site

Upper Saint Clair, Pennsylvania, 15241, United States

Location

Synergy Research Site

Greer, South Carolina, 29651, United States

Location

Synergy Research Site

Moncks Corner, South Carolina, 29461, United States

Location

Synergy Research Site

Bristol, Tennessee, 37620, United States

Location

Synergy Research Site

Franklin, Tennessee, 37064, United States

Location

Synergy Research Site

Jefferson City, Tennessee, 37760, United States

Location

Synergy Research Site

Kingsport, Tennessee, 37660, United States

Location

Synergy Research Site

Knoxville, Tennessee, 37919, United States

Location

Synergy Research Site

Knoxville, Tennessee, 37938, United States

Location

Synergy Research Site

Memphis, Tennessee, 38119, United States

Location

Synergy Research Site

Nashville, Tennessee, 37211, United States

Location

Synergy Research Site

Arlington, Texas, 76012, United States

Location

Synergy Research Site

Austin, Texas, 78705, United States

Location

Synergy Research Site

Austin, Texas, 78731, United States

Location

Synergy Research Site

Austin, Texas, 78735, United States

Location

Synergy Research Site

Carrollton, Texas, 75007, United States

Location

Synergy Research Site

Carrollton, Texas, 75010, United States

Location

Synergy Research Site

Channelview, Texas, 77530, United States

Location

Synergy Research Site

Dallas, Texas, 75224, United States

Location

Synergy Research Site

Dallas, Texas, 75231, United States

Location

Synergy Research Site

Gonzales, Texas, 78629, United States

Location

Synergy Research Site

Houston, Texas, 77015, United States

Location

Synergy Research Site

Houston, Texas, 77025, United States

Location

Synergy Research Site

Houston, Texas, 77054, United States

Location

Synergy Research Site

Houston, Texas, 77062, United States

Location

Synergy Research Site

Pharr, Texas, 78577, United States

Location

Synergy Research Site

Plano, Texas, 75024, United States

Location

Synergy Research Site

Plano, Texas, 75075, United States

Location

Synergy Research Site

Plano, Texas, 75093, United States

Location

Synergy Research Site

Plano, Texas, 75903, United States

Location

Synergy Research Site

San Antonio, Texas, 78205, United States

Location

Synergy Research Site

San Antonio, Texas, 78215, United States

Location

Synergy Research Site

Draper, Utah, 84020, United States

Location

Synergy Research Site

Newport News, Virginia, 23606, United States

Location

Synergy Research Site

Sterling, Virginia, 20166, United States

Location

Synergy Research Site

Richland, Washington, 99352, United States

Location

Related Publications (4)

  • Cash BD, Sharma A, Walker A, Laitman AP, Chang L. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation. Neurogastroenterol Motil. 2023 Sep;35(9):e14632. doi: 10.1111/nmo.14632. Epub 2023 Jun 18.

  • Moshiree B, Schoenfeld P, Franklin H, Rezaie A. The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials. Clin Ther. 2022 Jan;44(1):98-110.e1. doi: 10.1016/j.clinthera.2021.11.009. Epub 2022 Jan 25.

  • Menees SB, Franklin H, Chey WD. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older. Clin Ther. 2020 Jul;42(7):1406-1414.e4. doi: 10.1016/j.clinthera.2020.05.012. Epub 2020 Jul 10.

  • DeMicco M, Barrow L, Hickey B, Shailubhai K, Griffin P. Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation. Therap Adv Gastroenterol. 2017 Nov;10(11):837-851. doi: 10.1177/1756283X17734697. Epub 2017 Oct 25.

MeSH Terms

Conditions

Constipation

Interventions

plecanatide

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Patrick H. Griffin
Organization
Synergy Pharmaceuticals Inc.

Study Officials

  • Mary Beth Layton

    Synergy Pharmaceuticals Inc.

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2014

First Posted

April 24, 2014

Study Start

April 1, 2014

Primary Completion

May 1, 2015

Study Completion

July 1, 2015

Last Updated

May 28, 2019

Results First Posted

March 14, 2019

Record last verified: 2019-05

Locations